Skip to main content
Sickle marrow: double, double toil and trouble.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice.
In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies.
DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical Implementation.
A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children.
Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis.
Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants.
Calming the storm in HLH.
In ALD, I feel the need for speed.